Stakeholders meeting Sept. 14
This article was originally published in The Tan Sheet
Executive Summary
FDA will continue the mandated meetings with agency stakeholders, this time at the Holiday Inn in Bethesda, Md., beginning at 9 a.m. Topics will include whether FDA should modify its consumer health protection role. Other topics concern the functions to which a user fee should be applied; where and to what extent third parties should contribute, with third parties including states, industry, testing labs or health professional organizations; what functions could allow more non-regulatory approaches such as educational or technical assistance; whether an FDA "gold standard" seal of approval should be adopted; and whether international regulatory collaborations benefit the American consumer...